Minoru Toyota

Title: Minoru Toyota: Innovator in Methylated CpG Island Amplification

Introduction

Minoru Toyota is a distinguished inventor based in Baltimore, MD (US). He has made significant contributions to the field of molecular biology, particularly in the area of methylated CpG island amplification. With a total of 2 patents, his work has implications for detecting age-associated disorders and evaluating cellular responses.

Latest Patents

Toyota's latest patents focus on a method for identifying methylated CpG containing nucleic acids. This innovative approach involves using a methylation-sensitive restriction endonuclease that cleaves unmethylated CpG sites. Additionally, the method employs an isoschizomer of the restriction endonuclease, which can cleave both methylated and unmethylated CpG sites. The process also includes amplification of the CpG-containing nucleic acid using CpG-specific oligonucleotide primers. Furthermore, his patents provide methods for detecting age-associated disorders and evaluating cellular responses to various agents. A kit for the detection of CpG containing nucleic acids is also included in his inventions.

Career Highlights

Minoru Toyota is affiliated with The Johns Hopkins University, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical diagnostics and therapeutic interventions.

Collaborations

Toyota has collaborated with notable researchers such as Jean-Pierre Issa and Stephen B Baylin. These partnerships have further enriched his research and contributed to the advancement of knowledge in molecular biology.

Conclusion

Minoru Toyota's innovative work in methylated CpG island amplification showcases his commitment to advancing scientific understanding and medical applications. His contributions are vital in the ongoing exploration of genetic and epigenetic factors in health and disease.